, Tracking Stock Market Picks
Enter Symbol:

up 78.61 %

HALOZYME THERAPEUTIC (HALO) rated Buy with price target $21 by UBS

Posted on: Tuesday,  Mar 3, 2015  1:25 PM ET by UBS

UBS rated Buy HALOZYME THERAPEUTIC (NASDAQ: HALO) on 03/03/2015. Previously UBS rated Buy HALOZYME THERAPEUTIC (NASDAQ: HALO) on 06/12/2014., when
the stock price was $10.10. Since then, HALOZYME THERAPEUTIC has gained 78.61% as of 08/27/2015's recent price of $18.04.
If you would have followed the previous UBS's recommendation on HALO, you would have gained 78.61% of your investment in 441 days.

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the endocrinology, oncology, dermatology and drug delivery markets The Company's products are based on the property covering the family of human enzymes known as hyaluronidases. The Company has two marketed products: HYLENEX, a product used as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids, and Cumulase, a product used for in vitro fertilization (IVF). The Company has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. (Roche), to apply Enhanze Technology to Roche?s biological therapeutic compounds for up to 13 targets, and with Baxter Healthcare Corporation (Baxter), to apply Enhanze Technology to Baxter?s biological therapeutic compound, GAMMAGARD LIQUID.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2015 1:25 PM Buy
15.23 21.00
as of 8/27/2015
1 Week down  -14.58 %
1 Month down  -17.32 %
3 Months up  10.60 %
1 YTD up  18.45 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2014 12:00 AM Buy
10.10 16.00
11/11/2013 11:25 AM Hold
12.88 14.00
5/1/2013 10:25 AM Hold
5.78 6.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy